{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-010901","form_type":"8-K","ticker":"MTNB","cik":"0001582554","company_name":"Matinas BioPharma Holdings, Inc.","filed_at":"2024-03-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.699123+00:00","generated_at":"2026-06-04T09:02:53.098123+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Matinas BioPharma regains NYSE American continued listing compliance","bullets":["Received notification on March 21, 2024, resolving low selling price deficiency under Section 1003(f)(v).","Common stock demonstrated sustained price improvement, curing the non-compliance.","'.BC' indicator discontinued at market open on March 22, 2024; removed from noncompliant issuers list.","NYSE American confirmed continued listing standard is now satisfied."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-010901","json":"https://secwatch.observer/filing/0001493152-24-010901.json","markdown":"https://secwatch.observer/filing/0001493152-24-010901.md","text":"https://secwatch.observer/filing/0001493152-24-010901.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1582554/000149315224010901/0001493152-24-010901-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1582554/000149315224010901/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T09:02:53.098123+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}